On the other hand, in advanced stages of the disease (stages III and IV), despite the similar composition in apoA-I and lipids, HDL showed a lower ability to remove cholesterol from macrophages compared to HDL in the early clinical stages of BC (38). This evidence concerns the gene APOA1 and breast cancer.